Anti-CD28 antibodies modify regulatory mechanisms and reinforce tolerance in CD40Ig-treated heart allograft recipients

Journal of Immunology

Volumn 179, Issue 12, 2007, Pages 8164-8171

  Guillonneau, Carole ^a   Séveno, Céline ^a   Dugast, Anne Sophie ^a   Li, Xian Liang ^a   Renaudin, Karine ^a   Haspot, Fabienne ^a   Usal, Claire ^a   Veziers, Joëlle ^a   Anegon, Ignacio ^a,b   Vanhove, Bernard ^a,b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALLOANTIBODY; B7 ANTIGEN; CD28 ANTIGEN; CD40 ANTIGEN; CD40 ANTIGEN PLUS IMMUNOGLOBULIN G1; CD40 LIGAND; CD45 ANTIGEN; CD8 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN G1; IMMUNOSUPPRESSIVE AGENT; JJ 319; LEUKOCYTE ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY CD28; UNCLASSIFIED DRUG; CD40IG PROTEIN, RECOMBINANT; HYBRID PROTEIN; MONOCLONAL ANTIBODY;

ACUTE GRAFT REJECTION; ADOPTIVE TRANSFER; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CARDIAC GRAFT REJECTION; CD8+ T LYMPHOCYTE; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; GENE TRANSFER; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSTIMULATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; RAT; RAT STRAIN; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; TREATMENT OUTCOME; ANIMAL; CELL CLONE; CONGENIC STRAIN; GRAFT REJECTION; IMMUNOLOGY; LEWIS RAT; METABOLISM; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANIMALS, CONGENIC; ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; ANTIGENS, CD45; ANTIGENS, CD8; CLONE CELLS; CYTOKINES; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNE TOLERANCE; MALE; RATS; RATS, INBRED LEW; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, REGULATORY;

EID: 40049105939     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.12.8164     Document Type: Article

References (42)

1. Larsen, C. P., E. T. Elwood, D. Z. Alexander, S. C. Ritchie, R. Hendrix, C. Tucker-Burden, H. R. Cho, A. Aruffo, D. Hollenbaugh, P. S. Linsley, et al. 1996. Long-term acceptance of cardiac allografts after blocking CD40 and CD28 pathways. Nature 381: 434-439.
2. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14: 233-258.
3. Grewal, I. S., and R. A. Flavell. 1996. The role of CD40 ligand in costimulation and T-cell activation. Immunol. Rev. 153: 85-106.
4. Shimizu, K., U. Schonbeck, F. Mach, P. Libby, and R. N. Mitchell. 2000. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. J. Immunol. 165: 3506-3518.
5. Shirasugi, N., A. B. Adams, M. M. Durham, A. E. Lukacher, H. Xu, P. Rees, S. R. Cowan, M. A. Williams, T. C. Pearson, and C. P. Larsen. 2002. Prevention of chronic rejection in murine cardiac allografts: a comparison of chimerism- and nonchimerism-inducing costimulation blockade-based tolerance induction regimens. J. Immunol. 169: 2677-2684.
6. Guillot, C., P. Mathieu, H. Coathalem, B. Le Mauff, M. G. Castro, L. Tesson, C. Usal, T. Laumonier, S. Brouard, J. P. Soulillou, et al. 2000. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression. J. Immunol. 164: 5258-5268.
7. Guillot, C., C. Guillonneau, P. Mathieu, C. A. Gerdes, S. Menoret, C. Braudeau, L. Tesson, K. Renaudin, M. G. Castro, P. R. Lowenstein, and I. Anegon. 2002. Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection. J. Immunol. 168: 1600-1609.
8. Yamashita, K., T. Masunaga, N. Yanagida, M. Takehara, T. Hashimoto, T. Kobayashi, H. Echizenya, N. Hua, M. Fujita, M. Murakami, et al. 2003. Long-term acceptance of rat cardiac allografts on the basis of adenovirus mediated CD40Ig plus CTLA4Ig gene therapies. Transplantation 76: 1089-1096.
9. Adams, A. B., N. Shirasugi, T. R. Jones, M. M. Durham, E. A. Strobert, S. Cowan, P. Rees, R. Hendrix, K. Price, N. S. Kenyon, et al. 2005. Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival. J. Immunol. 174: 542-550.
10. Guillonneau, C., M. Hill, F. X. Hubert, E. Chiffoleau, C. Herve, X. L. Li, M. Heslan, C. Usal, L. Tesson, S. Menoret, et al. 2007. CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-γ, and indoleamine 2,3-dioxygenase. J. Clin. Invest. 117: 1096-1106.
11. Dengler, T. J., G. Szabo, B. Sido, W. Nottmeyer, R. Zimmerman, C. F. Vahl, T. Hunig, and S. C. Meuer. 1999. Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation. Transplantation 67: 392-398.
12. Grohmann, U., C. Orabona, F. Fallarino, C. Vacca, F. Calcinaro, A. Falorni, P. Candeloro, M. L. Belladonna, R. Bianchi, M. C. Fioretti, and P. Puccetti. 2002. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3: 1097-1101.
13. Guillot, C., S. Menoret, C. Guillonneau, C. Braudeau, M. G. Castro, P. Lowenstein, and I. Anegon. 2003. Active suppression of allogeneic proliferative responses by dendritic cells after induction of long-term allograft survival by CTLA4Ig. Blood 101: 3325-3333.
14. Tsai, M. K., H. N. Ho, H. F. Chien, P. Ou-Yang, C. J. Lee, and P. H. Lee. 2004. The role of B7 ligands (CD80 and CD86) in CD152-mediated allograft tolerance: a crosscheck hypothesis. Transplantation 77: 48-54.
15. Haspot, F., F. Villemain, G. Laflamme, F. Coulon, D. Olive, J. Tiollier, J. P. Soulillou, and B. Vanhove. 2002. Differential effect of CD28 versus B7 blockade on direct pathway of allorecognition and self-restricted responses. Blood 99: 2228-2234.
16. Perrin, P. J., C. H. June, J. H. Maldonado, R. B. Ratts, and M. K. Racke. 1999. Blockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 163: 1704-1710.
17. Silver, P. B., K. S. Hathcock, C. C. Chan, B. Wiggert, and R. R. Caspi. 2000. Blockade of costimulation through B7/CD28 inhibits experimental autoimmune uveoretinitis, but does not induce long-term tolerance. J. Immunol. 165: 5041-5047.
18. Yu, X. Z., S. J. Bidwell, P. J. Martin, and C. Anasetti. 2000. CD28-specific antibody prevents graft-versus-host disease in mice. J. Immunol. 164: 4564-4568.
19. Tacke, M., G. J. Clark, M. J. Dallman, and T. Hunig. 1995. Cellular distribution and costimulatory function of rat CD28: regulated expression during thymocyte maturation and induction of cyclosporin A sensitivity of costimulated T cell responses by phorbol ester. J. Immunol. 154: 5121-5127.
20. Tacke, M., G. Hanke, T. Hanke, and T. Hunig. 1997. CD28-mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: evidence for functionally distinct forms of CD28. Eur. J. Immunol. 27: 239-247.
21. Laskowski, I. A., J. Pratschke, M. J. Wilhelm, V. M. Dong, F. Beato, M. Taal, M. Gasser, W. W. Hancock, M. H. Sayegh, and N. L. Tilney. 2002. Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats. J. Am. Soc. Nephrol. 13: 519-527.
22. Haspot, F., C. Seveno, A. S. Dugast, F. Coulon, K. Renaudin, C. Usal, M. Hill, I. Anegon, M. Heslan, R. Josien, et al. 2005. Anti-CD28 antibody-induced kidney allograft tolerance related to tryptophan degradation and TCR class II B7 regulatory cells. Am. J. Transplant. 5: 2339-2348.
23. Dong, V. M., X. Yuan, A. J. Coito, A. M. Waaga, M. H. Sayegh, and A. Chandraker. 2002. Mechanisms of targeting CD28 by a signaling monoclonal antibody in acute and chronic allograft rejection. Transplantation 73: 1310-1317.
24. Ono, K., and E. S. Lindsey. 1969. Improved technique of heart transplantation in rats. J. Thorac. Cardiovasc. Surg. 57: 225-229.
25. David, A., H. Coupel-Clauce, J. Chetritt, L. Tesson, A. Cassard, B. Charreau, J. P. Soulillou, and I. Anegon. 1998. Anti-adenovirus immune responses in rats are enhanced by interleukin 4 but not interleukin 10 produced by recombinant adenovirus. Hum. Gene Ther. 9: 1755-1768.
26. Guillonneau, C., C. Louvet, K. Renaudin, J. M. Heslan, M. Heslan, L. Tesson, C. Vignes, C. Guillot, Y. Choi, L. A. Turka, et al. 2004. The role of TNF-related activation-induced cytokine-receptor activating NF-κ B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection. J. Immunol. 172: 1619-1629.
27. Braudeau, C., D. Bouchet, C. Toquet, L. Tesson, S. Menoret, S. Iyer, C. Laboisse, D. Willis, A. Jarry, R. Buelow, et al. 2003. Generation of heme oxygenase-1-transgenic rats. Exp. Biol. Med. 228: 466-471.
28. Braudeau, C., D. Bouchet, L. Tesson, S. Iyer, S. Remy, R. Buelow, I. Anegon, and C. Chauveau. 2004. Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer. Gene Ther. 11: 701-710.
29. Pannetier, C., J. Even, and P. Kourilsky. 1995. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol. Today 16: 176-181.
30. + repertoire during antiviral therapy. Nat. Med. 4: 215-221.
31. Gagne, K., S. Brouard, M. Giral, F. Sebille, A. Moreau, M. Guillet, J. D. Bignon, B. M. Imbert, M. C. Cuturi, and J. P. Soulillou. 2000. Highly altered V β repertoire of T cells infiltrating long-term rejected kidney allografts. J. Immunol. 164: 1553-1563.
32. + T lymphocytes regulating Th2 pathology escape neonatal tolerization. J. Immunol. 171: 5071-5076.
33. + regulatory T cells generated by neonatal recognition of peripheral self-antigen. Proc. Natl. Acad. Sci. USA 103: 15142-15147.
34. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
35. + regulatory T cells. J. Immunol. 171: 3348-3352.
36. Lyddane, C., B. U. Gajewska, E. Santos, P. D. King, G. C. Furtado, and M. Sadelain. 2006. Cutting edge: CD28 controls dominant regulatory T cell activity during active immunization. J. Immunol. 176: 3306-3310.
37. Vacchio, M. S., and R. J. Hodes. 2003. CD28 costimulation is required for in vivo induction of peripheral tolerance in CD8 T cells. J. Exp. Med. 197: 19-26.
38. + regulatory T cells. Invest. Ophthalmol. Visual Sci. 47: 5376-5384.
39. Cortesini, R., and N. Suciu-Foca. 2004. The concept of "partial" clinical tolerance. Transpl. Immunol. 13: 101-104.
40. Wu, G., S. Pfeiffer, C. Schroder, T. Zhang, B. N. Nguyen, W. Lea, S. Kelishadi, J. B. Atkinson, H. J. Schuurman, D. J. White, et al. 2005. Co-stimulation blockade targeting CD154 and CD28/B7 modulates the induced antibody response after a pig-to-baboon cardiac xenograft. Xenotransplantation 12: 197-208.
41. Fallarino, F., P. E. Fields, and T. F. Gajewski. 1998. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28. J. Exp. Med. 188: 205-210.
42. Chandraker, A., V. Huurman, K. Hallett, X. Yuan, A. J. Tector, C. H. Park, E. Lu, N. Zavazava, and M. Oaks. 2005. CTLA-4 is important in maintaining long-term survival of cardiac allografts. Transplantation 79: 897-903.